05.17.24 -- Tips For Master Data Management

Allan Shaw rejoins Business of Biotech to expose the murky role PBMs play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the rebate structure and shares why the model leaves patients and manufacturers stuck with the spiraling tab. He also explains why an election year, all-time lows in public perception of the pharma industry, and inflation might create the perfect storm for real change.

Discover why achieving true diversity demands more than rhetoric — requiring genuine engagement, cultural humility, and a commitment to addressing the unique needs of marginalized communities.

It is crucial to ensure that CGT supply chain risks are mitigated and to have proactive strategies in place to address unforeseen challenges before they become an issue.

Navigating the complex landscape of clinical trials can be challenging. Utilize this reliable CRO Checklist to empower teams to stay ahead and safeguard every trial's budget effectively.

Streamline the downstream process using variable pathlength technology to determine the DBC of affinity chromatography resins to produce reliable data more effectively and efficiently.

Learn what this author has to say about focusing on a clinical trial's outcome when developing Risk-Based Quality Management strategies.

Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.